Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001890187 | SCV002137607 | uncertain significance | Nephronophthisis | 2021-11-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with IQCB1-related conditions. This variant is present in population databases (rs370233738, gnomAD 0.002%). This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 91 of the IQCB1 protein (p.Cys91Tyr). |
Fulgent Genetics, |
RCV002478215 | SCV002776986 | uncertain significance | Senior-Loken syndrome 5 | 2022-01-20 | criteria provided, single submitter | clinical testing |